Pointe Scientific, Inc, Canton, MI is initiating a nationwide recall of all size kits of Liquid Glucose Hexokinase Reagent catalog number G7517. The reagents have been found to fail linearity at > 200mg/dL that results in inaccurate glucose values above this range.
More:
Pointe Scientific, Inc Expands Nationwide Recall of Liquid Glucose Hexokinase Reagent (G7517)
Pointe Scientific, Inc, Canton, MI is initiating a nationwide recall of all size kits of Liquid Glucose Hexokinase Reagent catalog number G7517. The reagents have been found to fail linearity at > 200mg/dL that results in inaccurate glucose values above this range.
Read more from the original source:
Pointe Scientific, Inc Issues Nationwide Recall of Liquid Glucose Hexokinase Reagent (G7517)
The U.S. Food and Drug Administration today announced an action regarding the implementation of the Family Smoking Prevention and Tobacco Control Act.
Read more from the original source:
FDA Moves Forward on Implementation of Tobacco Law
On March 23, 2009, a federal court issued an order directing the FDA, within 30 days, to permit the Plan B drug sponsor to make Plan B available to women 17 and older without a prescription. The government will not appeal this decision.
Read more:
Updated FDA Action on Plan B (levonorgestrel) Tablets
An in-depth analysis of blood from patients recovering from the H5N1 avian influenza virus has provided important insights into how to combat the potentially lethal virus.
Read the original here:
FDA Researchers Contribute Insights into Avian Flu Virus